WATSON 3359 WATSON 3359 (Tacrolimus 5 mg)
Pill with imprint WATSON 3359 WATSON 3359 is Pink, Capsule-shape and has been identified as Tacrolimus 5 mg. It is supplied by Watson Laboratories, Inc..
Tacrolimus is used in the treatment of organ transplant, rejection prophylaxis; organ transplant, rejection reversal and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 3359 WATSON 3359
Tacrolimus
- Imprint
- WATSON 3359 WATSON 3359
- Strength
- 5 mg
- Color
- Pink
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Calcineurin inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-3359
- Inactive Ingredients
-
lactose anhydrous, croscarmellose sodium, hypromelloses, magnesium stearate, gelatin, titanium dioxide, FD&C Blue No. 1, FD&C Red No. 3, FD&C Red No. 40
Note: Inactive ingredients may vary.
More about tacrolimus
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 42 Reviews
- Drug class: calcineurin inhibitors
- FDA Alerts (1)
Consumer resources
- Tacrolimus oral and injection
- Tacrolimus Extended-Release Tablets
- Tacrolimus Capsules
- Tacrolimus Extended-Release Capsules
- Tacrolimus Granules for Suspension
- ... +3 more
Other brands: Prograf, Envarsus XR, Astagraf XL, Hecoria
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
